Association between biological aging and lung cancer risk: Cohort study and Mendelian randomization analysis

Summary: Chronological age only represents the passage of time, whereas biological age reflects the physiology states and the susceptibility to morbidity and mortality. The association between biological age and lung cancer risk remains controversial. Hence, we conducted a prospective analysis in th...

Full description

Bibliographic Details
Main Authors: Zhimin Ma, Chen Zhu, Hui Wang, Mengmeng Ji, Yanqian Huang, Xiaoxia Wei, Jing Zhang, Yuzhuo Wang, Rong Yin, Juncheng Dai, Lin Xu, Hongxia Ma, Zhibin Hu, Guangfu Jin, Meng Zhu, Hongbing Shen
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004223000950
_version_ 1797905362275270656
author Zhimin Ma
Chen Zhu
Hui Wang
Mengmeng Ji
Yanqian Huang
Xiaoxia Wei
Jing Zhang
Yuzhuo Wang
Rong Yin
Juncheng Dai
Lin Xu
Hongxia Ma
Zhibin Hu
Guangfu Jin
Meng Zhu
Hongbing Shen
author_facet Zhimin Ma
Chen Zhu
Hui Wang
Mengmeng Ji
Yanqian Huang
Xiaoxia Wei
Jing Zhang
Yuzhuo Wang
Rong Yin
Juncheng Dai
Lin Xu
Hongxia Ma
Zhibin Hu
Guangfu Jin
Meng Zhu
Hongbing Shen
author_sort Zhimin Ma
collection DOAJ
description Summary: Chronological age only represents the passage of time, whereas biological age reflects the physiology states and the susceptibility to morbidity and mortality. The association between biological age and lung cancer risk remains controversial. Hence, we conducted a prospective analysis in the UK Biobank study and two-sample Mendelian randomization analysis to investigate this association. Biological aging was evaluated by PhenoAgeAccel, derived from routine clinical biomarkers. Independent of chronological age, PhenoAgeAccel was positively associated with the risk of overall and histological subtypes of lung cancer. There was a joint effect of PhenoAgeAccel and genetics in lung cancer incidence. In Mendelian randomization analysis, the genetically predicted PhenoAgeAccel was associated with the increased risk of overall lung cancer, small cell, and squamous cell carcinoma. Our findings suggest PhenoAgeAccel is an independent risk factor for lung cancer, which could be incorporated with polygenic risk score to identify high-risk individuals for lung cancer.
first_indexed 2024-04-10T10:04:03Z
format Article
id doaj.art-eace7c13b9994e249ca6d13ea46675b3
institution Directory Open Access Journal
issn 2589-0042
language English
last_indexed 2024-04-10T10:04:03Z
publishDate 2023-03-01
publisher Elsevier
record_format Article
series iScience
spelling doaj.art-eace7c13b9994e249ca6d13ea46675b32023-02-16T04:18:40ZengElsevieriScience2589-00422023-03-01263106018Association between biological aging and lung cancer risk: Cohort study and Mendelian randomization analysisZhimin Ma0Chen Zhu1Hui Wang2Mengmeng Ji3Yanqian Huang4Xiaoxia Wei5Jing Zhang6Yuzhuo Wang7Rong Yin8Juncheng Dai9Lin Xu10Hongxia Ma11Zhibin Hu12Guangfu Jin13Meng Zhu14Hongbing Shen15Department of Epidemiology, School of Public Health, Southeast University, Nanjing 210009, China; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, ChinaDepartment of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China; Department of Cancer Prevention, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou 310022, China; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou 310022, ChinaDepartment of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, ChinaDepartment of Epidemiology, School of Public Health, Southeast University, Nanjing 210009, China; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, ChinaDepartment of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, ChinaDepartment of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, ChinaDepartment of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, ChinaDepartment of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China; Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, ChinaDepartment of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, ChinaDepartment of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, ChinaDepartment of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, ChinaDepartment of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China; Research Units of Cohort Study on Cardiovascular Diseases and Cancers, Chinese Academy of Medical Sciences, Beijing 100000, ChinaDepartment of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, ChinaDepartment of Epidemiology, School of Public Health, Southeast University, Nanjing 210009, China; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China; Corresponding authorDepartment of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China; Corresponding authorDepartment of Epidemiology, School of Public Health, Southeast University, Nanjing 210009, China; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China; Department of Cancer Prevention, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou 310022, China; Research Units of Cohort Study on Cardiovascular Diseases and Cancers, Chinese Academy of Medical Sciences, Beijing 100000, China; Corresponding authorSummary: Chronological age only represents the passage of time, whereas biological age reflects the physiology states and the susceptibility to morbidity and mortality. The association between biological age and lung cancer risk remains controversial. Hence, we conducted a prospective analysis in the UK Biobank study and two-sample Mendelian randomization analysis to investigate this association. Biological aging was evaluated by PhenoAgeAccel, derived from routine clinical biomarkers. Independent of chronological age, PhenoAgeAccel was positively associated with the risk of overall and histological subtypes of lung cancer. There was a joint effect of PhenoAgeAccel and genetics in lung cancer incidence. In Mendelian randomization analysis, the genetically predicted PhenoAgeAccel was associated with the increased risk of overall lung cancer, small cell, and squamous cell carcinoma. Our findings suggest PhenoAgeAccel is an independent risk factor for lung cancer, which could be incorporated with polygenic risk score to identify high-risk individuals for lung cancer.http://www.sciencedirect.com/science/article/pii/S2589004223000950Health sciencesRisk stratificationCancer
spellingShingle Zhimin Ma
Chen Zhu
Hui Wang
Mengmeng Ji
Yanqian Huang
Xiaoxia Wei
Jing Zhang
Yuzhuo Wang
Rong Yin
Juncheng Dai
Lin Xu
Hongxia Ma
Zhibin Hu
Guangfu Jin
Meng Zhu
Hongbing Shen
Association between biological aging and lung cancer risk: Cohort study and Mendelian randomization analysis
iScience
Health sciences
Risk stratification
Cancer
title Association between biological aging and lung cancer risk: Cohort study and Mendelian randomization analysis
title_full Association between biological aging and lung cancer risk: Cohort study and Mendelian randomization analysis
title_fullStr Association between biological aging and lung cancer risk: Cohort study and Mendelian randomization analysis
title_full_unstemmed Association between biological aging and lung cancer risk: Cohort study and Mendelian randomization analysis
title_short Association between biological aging and lung cancer risk: Cohort study and Mendelian randomization analysis
title_sort association between biological aging and lung cancer risk cohort study and mendelian randomization analysis
topic Health sciences
Risk stratification
Cancer
url http://www.sciencedirect.com/science/article/pii/S2589004223000950
work_keys_str_mv AT zhiminma associationbetweenbiologicalagingandlungcancerriskcohortstudyandmendelianrandomizationanalysis
AT chenzhu associationbetweenbiologicalagingandlungcancerriskcohortstudyandmendelianrandomizationanalysis
AT huiwang associationbetweenbiologicalagingandlungcancerriskcohortstudyandmendelianrandomizationanalysis
AT mengmengji associationbetweenbiologicalagingandlungcancerriskcohortstudyandmendelianrandomizationanalysis
AT yanqianhuang associationbetweenbiologicalagingandlungcancerriskcohortstudyandmendelianrandomizationanalysis
AT xiaoxiawei associationbetweenbiologicalagingandlungcancerriskcohortstudyandmendelianrandomizationanalysis
AT jingzhang associationbetweenbiologicalagingandlungcancerriskcohortstudyandmendelianrandomizationanalysis
AT yuzhuowang associationbetweenbiologicalagingandlungcancerriskcohortstudyandmendelianrandomizationanalysis
AT rongyin associationbetweenbiologicalagingandlungcancerriskcohortstudyandmendelianrandomizationanalysis
AT junchengdai associationbetweenbiologicalagingandlungcancerriskcohortstudyandmendelianrandomizationanalysis
AT linxu associationbetweenbiologicalagingandlungcancerriskcohortstudyandmendelianrandomizationanalysis
AT hongxiama associationbetweenbiologicalagingandlungcancerriskcohortstudyandmendelianrandomizationanalysis
AT zhibinhu associationbetweenbiologicalagingandlungcancerriskcohortstudyandmendelianrandomizationanalysis
AT guangfujin associationbetweenbiologicalagingandlungcancerriskcohortstudyandmendelianrandomizationanalysis
AT mengzhu associationbetweenbiologicalagingandlungcancerriskcohortstudyandmendelianrandomizationanalysis
AT hongbingshen associationbetweenbiologicalagingandlungcancerriskcohortstudyandmendelianrandomizationanalysis